Clinical Trials Browser

Expanded_access × Sunitinib × Genitourinary × Clear all

NCT00130897 2012-03-09

Treatment Use Study With Sunitinib (SU011248) For Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma

Approved for marketing

Carcinoma, Renal Cell